Home > Products > CD64 & HER2
> Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG)
Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-128)
Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD64 and anti-HER2 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) (BSIG-128). Click the button below to contact us or submit your feedback about this product.